Wybierz swój kraj lub region

Teraz jesteś w Poland (Polski)
Strona główna / O nas / Investors
The Share Arjo B 19 mar 2024 12:01 4,74 USD (+1,18%)
3_New_Joacim Lindoff_banner_textblock.jpg

Year-end report 2023

We are ending 2023 with healthy growth, significantly improved earnings and strong operating cash flow. During the year considerable focus was put on profitable growth in a market characterized by stabilization and recovery. We are now continuing our efforts to further strengthen our positions during 2024 and beyond.”

A sustainable healthcare – the core of our business

Research shows that there is a clear connection between mobility and people’s physical and mental well-being. We have seen how increased patient mobility can quickly improve both clinical and financial outcomes. As leading specialists in the field our role is to make more high-quality care available to more people, and thereby contribute to a sustainable healthcare.

Arjo.Calendar icon blue.jpg

Founded by Arne Johansson in Eslöv in 1957

Arjo.Team group icon blue.jpg

Approximately 6,500 employees

Arjo.Globe icon blue.jpg

Sells solutions and products in more than 100 countries

Arjo.Leaf environment icon blue.jpg

Contributes to sustainable healthcare

Arjo.Positive line chart icon blue.jpg

Net sales of about SEK 11 billion in 2023

Arjo.Office icon blue.jpg

Five product development and production units worldwide

Rehab Final 376_376.jpg

Investment case

Over the years, Arjo has built up extensive expertise and developed market-leading solutions that contribute to increased safety and quality of life for patients, improved work environment for healthcare staff and better resource efficiency for healthcare providers. With the healthcare sector facing significant challenges, Arjo is well-positioned to contribute to long-term sustainable care.

AGM FINAL_773_652.jpg

2024

Annual General Meeting

Arjo AB's Annual General Meeting will be held on April 18th, 2024.

JoacimCMDFINAL_376_328.jpg

Capital Markets Day

On October 28th, 2022 President and CEO Joacim Lindoff together with members of Arjo's Mangement Team provided an update on the Group’s strategy implementation and expected development for the coming years.

AR_FINAL_376_376.jpg

Our latest Annual and Sustainability Report

Read our most recent Annual and Sustainability Report.

Arjo.Positive trend icon blue.jpg

The Arjo share

Information about the major shareholders, share price, dividend and total return as well as analysts.

Sara Ehinger IR.jpg

Contact

Sara Ehinger
VP Investor Relations & Corporate Communications
Phone: +46 723 597 794 
Email: sara.ehinger@arjo.com

Subscribe

Subscribe to our latest news, press releases and financial reports

blue background.jpg

Strona zawiera materiały przeznaczone wyłącznie dla profesjonalistów z branży medycznej lub farmaceutycznej (przedstawiciele zawodów medycznych, w tym pracownicy aptek, laboratoriów diagnostycznych, podmiotów leczniczych, itp.).

Jeżeli nie jesteś profesjonalistą z branży medycznej lub farmaceutycznej zaznacz to w odpowiedzi poniżej. W przeciwnym razie uzyskasz dostęp do materiałów niedopuszczalnych dla Ciebie ze względu na obowiązujące przepisy prawa dotyczące reklamy wyrobów medycznych.

Nie jestem profesjonalistą
Kontakt